SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Onur Boyman, Denis Comte, François Spertini, Adverse reactions to biologic agents and their medical management, Nature Reviews Rheumatology, 2014, 10, 10, 612

    CrossRef

  2. 2
    T. Orban, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, P. A. Gottlieb, C. J. Greenbaum, J. B. Marks, R. Monzavi, A. Moran, M. Peakman, P. Raskin, W. E. Russell, D. Schatz, D. K. Wherrett, D. M. Wilson, J. P. Krischer, J. S. Skyler, Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment, Diabetes Care, 2014, 37, 4, 1069

    CrossRef

  3. 3
    Charlotte Hua, Thomas Barnetche, Bernard Combe, Jacques Morel, Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis, Arthritis Care & Research, 2014, 66, 7
  4. 4
    M. Gaubitz, K. Krüger, J.-P. Haas, Empfehlungen zum Einsatz von Abatacept bei Patienten mit rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2014, 73, 10, 942

    CrossRef

  5. 5
    Meliha C Kapetanovic, Lars-Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner, Pierre Geborek, Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis, Arthritis Research & Therapy, 2014, 16, 1, R2

    CrossRef

  6. 6
    C. Kneitz, A. Strangfeld, K. Krüger, Prophylaxe und Behandlung von Infektionen beim älteren Rheumapatienten, Zeitschrift für Rheumatologie, 2014, 73, 3, 225

    CrossRef

  7. 7
    F. Milanetti, V. Germano, R. Nisini, I. Donatelli, A. Di Martino, M. Facchini, C. Ferlito, A. Cappella, D. Crialesi, S. Caporuscio, R. Biselli, F. Rossi, S. Salemi, R. D'Amelio, Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals, Clinical & Experimental Immunology, 2014, 177, 1
  8. 8
    K. Minden, F. Speth, H.-I. Huppertz, M. Borte, Sinnvolle Impfprävention bei Kindern und Jugendlichen mit rheumatischen und muskuloskelettalen Erkrankungen, Zeitschrift für Rheumatologie, 2014, 73, 10, 878

    CrossRef

  9. 9
    Helena H. Askling, Virgil A.S.H. Dalm, The medically immunocompromised adult traveler and pre-travel counseling: Status quo 2014, Travel Medicine and Infectious Disease, 2014, 12, 3, 219

    CrossRef

  10. 10
    Johanna Westra, Christien Rondaan, Sander van Assen, Marc Bijl, Vaccination of patients with autoimmune inflammatory rheumatic diseases, Nature Reviews Rheumatology, 2014,

    CrossRef

  11. 11
    Lisa M. Perry, Kevin L. Winthrop, Jeffrey R. Curtis, Vaccinations for Rheumatoid Arthritis, Current Rheumatology Reports, 2014, 16, 8

    CrossRef

  12. 12
    I. Ferreira, D. Isenberg, Vaccines and biologics, Annals of the Rheumatic Diseases, 2014, 73, 8, 1446

    CrossRef

  13. 13
    Robert Eisenberg, Stiehm's Immune Deficiencies, 2014,

    CrossRef

  14. 14
    Adriana Weinberg, David Boulware, Bonnie Dighero, Tihamer Orban, Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes, Vaccine, 2013, 31, 42, 4791

    CrossRef

  15. 15
    Alejandra G. Begazo Cruz, Inmunización y quimioprofilaxis en pacientes con artritis reumatoide, Seminarios de la Fundación Española de Reumatología, 2013, 14, 2, 36

    CrossRef

  16. 16
    Meliha Crnkic Kapetanovic, Tore Saxne, Göran Jönsson, Lennart Truedsson, Pierre Geborek, Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis, Arthritis Research & Therapy, 2013, 15, 5, R171

    CrossRef

  17. 17
    Esther F Vicente Rabaneda, Gabriel Herrero-Beaumont, Santos Castañeda, Update on the use of abatacept for the treatment of rheumatoid arthritis, Expert Review of Clinical Immunology, 2013, 9, 7, 599

    CrossRef